Ozempic-like weight loss drugs may protect against Alzheimer's
UC expert comments on new research to NBC News
The University of Cincinnati's Alberto Espay, MD, was featured in a NBC News article commenting on new research that found a weight loss drug similar to Ozempic appeared to slow cognitive decline in patients with mild Alzheimer’s disease.
The research, presented Tuesday at the Alzheimer’s Association International Conference in Philadelphia, focused on liraglutide, the active ingredient used in some GLP-1 drugs. GLP-1 agonists are a class of medications that includes the popular diabetes and weight loss drugs Ozempic and Wegovy.
The midstage clinical trial included about 200 people in the United Kingdom who got daily injections of either liraglutide or a placebo. After one year, cognitive decline in the patients who got liraglutide had slowed by as much as 18% compared to those who didn’t get the drug, based on the Alzheimer’s Disease Assessment Scale, which tracks the progression of the disease by assessing memory, language, skills, understanding and reasoning abilities.
Espay said the fact that GLP-1s appear to help protect the brain makes sense, as Alzheimer's is thought to be a "syndrome of many diseases caused by different biological, toxic or infectious exposures.”
“This looks promising," said Espay, professor of neurology in the UC College of Medicine and director and endowed chair of the James J. and Joan A. Gardner Family Center for Parkinson’s Disease and Movement Disorders at the UC Gardner Neuroscience Institute. "If this is replicated in a phase 3 trial, it could become the first truly disease-modifying treatment in Alzheimer’s disease.”
Featured photo at top of liraglutide injection pen. Photo/Hailshadow/iStock.
Related Stories
UC professor warns against rising nicotine pouch use
November 10, 2026
Ashley Merianos, PhD, professor in the UC School of Human Services, spoke with Local 12 News in Cincinnati about her latest research showing a sharp increase in nicotine pouch use among adult tobacco users from 2021 to 2024.
Nurse practitioners are shaping the future of health care
November 10, 2026
From diagnosing illnesses and managing chronic conditions to advancing health policy and improving access to care, nurse practitioners play an increasingly important role in the nation's health care system. This week, Nov. 8–14, we celebrate National Nurse Practitioner Week and the more than 461,000 licensed nurse practitioners in the United States who provide high-quality, patient-centered care to millions of Americans — including the University of Cincinnati nurses who are stepping into the role right now.
Are women more susceptible to PTSD?
November 10, 2026
UC neuroscientist James Herman, PhD, and colleagues report that a specific stress hormone pattern in female animal models may signal vulnerability to PTSD, offering a potential biomarker to help explain why women are diagnosed at roughly twice the rate of men.